SHJ002

DRUG2 trials

Sponsors

Sunhawk Vision Biotech, Inc.

Conditions

Corneal ErosionMyopia, Progressive

Phase 2

Efficacy and Safety of SHJ002 Ophthalmic Solution in the Treatment of Corneal Erosion in Sjogren's Patients

CompletedNCT06381986

Sunhawk Vision Biotech, Inc.Corneal Erosion

Start: 2024-06-28End: 2025-04-17Updated: 2025-08-22

A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control

Active, not recruitingNCT06579287

Sunhawk Vision Biotech, Inc.Myopia, Progressive

Start: 2025-01-22End: 2026-12-01Updated: 2026-01-23